secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2022-08-09T23:59:59+00:00
Accession:  0000950170-22-016085
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q2 revenue $209.5M (+31%); net loss $68.7M; lowers FY revenue guidance to bottom of $865-885M range
--------------------------------------------------------------------------------

- Revenue $209.5M, +31% YoY; net loss $68.7M (incl $57.5M stock comp).
- Adjusted EBITDA $14.6M flat YoY; Center Margin $59.8M (28.5% of rev).
- Clinicians 5,226 (+31%); net add 237 in Q2; 4 acquisitions closed.
- FY2022 rev guidance lowered to bottom of $865-885M; Adj. EBITDA reaffirmed $63-67M; Q3 rev $216-221M.
- Danish Qureshi appointed COO effective July 1; OBIE online booking live in 9 states.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017022016085/0000950170-22-016085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017022016085/lfst-20220809.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-016085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer